These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9156942)

  • 21. Does calcium channel blocker improvement of perfusion impact the functioning of kidney graft in early period after transplantation?
    Nowacki M; Droździk M; Safranow K; Kaminski M; Sulikowski T; Zietek Z; Romanowski M; Sienko J; Mizerski A; Ignaczak E; Domanski L; Pabisiak K; Bohatyrewicz R; Ostrowski M
    Transplant Proc; 2008 May; 40(4):1056-8. PubMed ID: 18555114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium channel blockers: do they offer renal protection?
    Reams GP
    J Hum Hypertens; 1993 Jun; 7(3):211-9. PubMed ID: 8345486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium antagonists and the kidney.
    Pearce CJ; Wallin JD
    New Horiz; 1996 Feb; 4(1):123-8. PubMed ID: 8689267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal protection with the calcium antagonists.
    Neumayer HH; Kunzendorf U
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S11-8. PubMed ID: 1723449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of calcium-channel blockers in preventing acute and chronic renal injury.
    Schrier RW; Burke TJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S38-43. PubMed ID: 1725916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protective effects of calcium antagonists].
    Dzgoeva FU; Kutyrina IM
    Ter Arkh; 2000; 72(6):42-5. PubMed ID: 10900648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Learning experiences from UNC. Renal autoregulation, drugs, and acute renal failure.
    Blythe WB
    N C Med J; 1985 Jul; 46(7):413-4. PubMed ID: 2993929
    [No Abstract]   [Full Text] [Related]  

  • 28. [Calcium antagonists and renal protection].
    Ruilope LM; Campo C
    Med Clin (Barc); 1990 Sep; 95(10):377-9. PubMed ID: 2084401
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcium antagonists and the kidney: future therapeutic perspectives.
    Epstein M
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):16-25. PubMed ID: 8503430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity.
    Rodicio JL; Morales JM; Ruilope LM
    J Hypertens Suppl; 1993 Dec; 11(6):S21-5. PubMed ID: 8169378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of calcium antagonists on cyclosporin nephrotoxicity after clinical renal transplantation.
    Morales JM; Andres A; Rodicio JL
    Nephrol Dial Transplant; 1993; 8(9):880. PubMed ID: 8255527
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of calcium-channel blockers on renal function in renal-graft recipients treated with cyclosporine.
    Hauser AC; Derfler K; Stockenhuber F; Wamser P; Marosi L; Balcke P
    N Engl J Med; 1991 May; 324(21):1517. PubMed ID: 2023618
    [No Abstract]   [Full Text] [Related]  

  • 33. [Consequences of intravascular contrast media on kidney function-- risk and prevention].
    Erley CM; Bader BD
    Rofo; 2000 Oct; 172(10):791-7. PubMed ID: 11111289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcium antagonists and renal hemodynamics: implications for renal protection.
    Epstein M
    Clin Invest Med; 1991 Dec; 14(6):590-5. PubMed ID: 1794210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic use of theophylline to antagonize renal effects of adenosine.
    Osswald H; Gleiter C; Mühlbauer B
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S33-7. PubMed ID: 7781203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
    Asberg A; Christensen H; Hartmann A; Berg KJ
    Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-induced nephrotoxicity in renal allograft recipients.
    Ahuja TS; Niaz N; Agraharkar M
    Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal effects of calcium antagonists].
    Rodicio Díaz JL
    Rev Clin Esp; 1990 Feb; 186(3):105-7. PubMed ID: 2356347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.